Delhi Network Of Positive People (Dnp+) Opposition, Velpatasvir, (201627039572)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Delhi Network of Positive People (DNP+) opposition, Sofosbuvir/Velpatasvir, (201627008488)
Countries: India Date: 2018
-
Delhi Network of Positive People (DNP+) opposition, Glecaprevir / Pibrentasvir , (201817002543)
Countries: India Date: 2021
-
The Delhi Network of Positive People opposition, Glecaprevir / Pibrentasvir, (201817002543)
Countries: India Date: 2021
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)
Countries: India Date: 2014
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (PCT/US2012/065681 (4351/DELNP/2013))
Countries: India Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005))
Countries: India Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (9149/CHENP/2012)
Countries: India Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Glecaprevir, (2891/DELNP/2013)
Countries: India Date: 2019
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (806/DELNP/2010 (PCT/US2008/071734))
Countries: India Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (3999/CHENP/2012 (PCT/US2010/055045))
Countries: India Date: 2017